Z-1979-2019 Class II Terminated

Recalled by Roche Diagnostics Corporation — Indianapolis, IN

FDA device recall Z-1979-2019 was initiated by Roche Diagnostics Corporation on Jun 3, 2019 and is designated Class II. Reason for recall: Calibration failures with Std.E, Sens.E, or Dup.E error due to atypical reaction kinetics and quality control failures have occurred due to contamination of R1 reagent with R3 reagent. The recall status is terminated (terminated Aug 28, 2020). Affected quantity: 8 units.

Recall details

Product Type
Devices
Report Date
Jul 24, 2019
Initiation Date
Jun 3, 2019
Termination Date
Aug 28, 2020
Voluntary/Mandated
Voluntary: Firm initiated
Product Quantity
8 units

Product description

The Tina-quant lgA Gen.2 is an immunoturbidimetric assay. Anti-lgA antibodies react with antigen in the sample to form an antigen/antibody complex which is measured turbidimetrically.

Reason for recall

Calibration failures with Std.E, Sens.E, or Dup.E error due to atypical reaction kinetics and quality control failures have occurred due to contamination of R1 reagent with R3 reagent.

Distribution pattern

The products were distributed to the following US states: AL, IN, and KY.

Code information

Lot 368756

Source

Dataset
openFDA device recall enforcement reports
FDA record
This recall in openFDA (JSON)
Enforcement Report
Search FDA's Enforcement Report for Z-1979-2019
openFDA file date
Nov 16, 2026
Loaded by RegDataLab
Nov 17, 2026

These dates say when openFDA published the data file and when RegDataLab last loaded it.

Source: openFDA record for Z-1979-2019. Report a data issue: hello@regdatalab.com.